Sanctuary Advisors LLC Acquires New Holdings in The Cooper Companies, Inc. $COO

Sanctuary Advisors LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, Holdings Channel.com reports. The fund bought 29,478 shares of the medical device company’s stock, valued at approximately $2,114,000.

Several other hedge funds also recently bought and sold shares of COO. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the period. Root Financial Partners LLC raised its stake in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. Essential Partners LLC raised its stake in Cooper Companies by 23.4% during the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock worth $62,000 after buying an additional 166 shares during the period. Allworth Financial LP lifted its holdings in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its holdings in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Trading Down 0.5%

NASDAQ COO opened at $72.68 on Thursday. The stock has a market capitalization of $14.17 billion, a price-to-earnings ratio of 61.59, a PEG ratio of 1.91 and a beta of 0.83. The stock’s 50 day moving average price is $72.36 and its two-hundred day moving average price is $70.96. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on COO. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird lowered their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. BNP Paribas Exane dropped their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.